Genentech is a pioneering biotechnology company dedicated to advancing the frontiers of science and addressing some of the most pressing biomedical challenges faced by humanity. With a strong focus on innovation, Genentech offers a wide range of medicines and therapies, primarily in the fields of oncology, neuroscience, and ophthalmology. The company is committed to breaking scientific barriers and improving patient outcomes through groundbreaking research and inclusive clinical trials.

Genentech not only develops cutting-edge treatments but also provides invaluable resources to patients, including financial support services, disease education, and access to clinical trial information. Their Patient Foundation further reflects their commitment to empowering individuals in navigating their healthcare journey.

With a legacy built on collaboration and a vision for a healthier future, Genentech continues to be a leader in the biotechnology sector, fostering diversity and inclusion, and championing health equity. Their dedication to transforming society through science is at the heart of everything they do.